Enter Note Done
Go to previous page in this tab
Session
  • Presentation | Uncontrolled Therapeutic Observations in Humans Biologic
  • Poster Session
  • Share Icon
    Bookmark Icon
  • P037: A PHASE II OPEN LABEL STUDY OF NEIHULIZUMAB, AN ANTI-CD162 (PSGL-1) ANTIBODY, IN PATIENTS WITH MODERATE TO SEVERE ACTIVE, ANTI-TNFα AND/OR ANTI-INTEGRIN REFRACTORY ULCERATIVE COLITIS
    • Schedule
    Notes
  • Exhibit/Poster Hall (Aurora Halls 1/2) - Gaylord Resort
    Set Timezone


Speaker(s): David Rubin, Scott D Lee, Lucky Flores, Gustavo Albizu-Angulo, Ellen Scherl, Surinder Saini, Iming Cho, Shih-Yao Lin, Simona Reed, Jesse Hall
Types
Main Session
Discussion